Healthcare organizations and 22 states have sued to stop the cuts. The case is expected to reach the Supreme Court.

BMS’ Breyanzi and Amgen’s Blincyto will now be available to patients in England with certain types of blood cancer.

A judge on Friday extended a temporary block of the Trump Administration’s drastic cuts in medical research funding.

Blincyto plus chemo was approved for adult patients with Ph-negative, CD19-positive, and MRD-negative B-cell precursor acute lymphoblastic leukemia.

The epilepsy treatment is now approved as an add-on therapy for patients aged ≥ 2 years, following an appeal against NICE’s initial rejection.

A new treatment option has become available for severe epilepsy: fenfluramine, which is now available on the NHS ...

A father-of-two who is in remission from cancer is calling for the treatment which helped him to be made available on the NHS ...

Hundreds of children in England with a rare and severe form of epilepsy are set to benefit from a new drug being rolled out on the NHS. Fenfluramine has been recommended by the National Institute for ...

Part two of this series sees Ravijyot Saggu explore pharmacological management recommendations from the new joint chronic ...

But two-year funding for a new type of surgery in Wales - which until that point was only available elsewhere in the UK - ...

Recent guidance from the National Institute for Health and Care Excellence (NICE) urged GPs to consider asking at-risk ...